Our study showed that there was no notable change or deterioration in the hearing function of the patients with AS and RA who were treated with infliximab. PubMed, Clin Rheumatol, 2014 Oct;33(10):1481-7. (Also see: Rheumatoid Arthritis Treatments and Ankylosing Spondylitis)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.